Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-21-000593
Filing Date
2021-07-02
Accepted
2021-07-02 15:39:58
Documents
1
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1662
  Complete submission text file 0001192482-21-000593.txt   3126
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Issuer) CIK: 0001716947 (see all company filings)

EIN.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7946 IVANHOE AVENUE, SUITE 201 LA JOLLA CA 92037
Business Address
Millard Jeffrey (Reporting) CIK: 0001868808 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38306 | Film No.: 211069722